Status:
RECRUITING
Biofeedback for Hemianopia Vision Rehabilitation
Lead Sponsor:
University Health Network, Toronto
Collaborating Sponsors:
University of Toronto
Conditions:
Hemianopsia, Homonymous
Brain Injury
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
Patients with brain injury secondary to stroke, surgery, or trauma frequently suffer from homonymous hemianopia, defined as vision loss in one hemifield secondary to retro- chiasmal lesion. Classic an...
Detailed Description
Background Patients with brain injury secondary to stroke, surgery, or trauma frequently suffer from homonymous hemianopia, defined as vision loss in one hemifield secondary to retro- chiasmal lesion...
Eligibility Criteria
Inclusion
- hemianopia cases previously diagnosed accordingly by microperimetry and other tests as needed
- 18-90 years old
- ability to follow the visual and auditory stimuli and training instructions
Exclusion
- previous or current treatment for low vision rehabilitation
- ocular diseases
- other serious clinical conditions not related to the hemianopia physiopathology
- both eyes with media opacity that impairs microperimetry testing
- lack of ability to perform the tests and training
Key Trial Info
Start Date :
December 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2026
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT05397873
Start Date
December 1 2021
End Date
July 1 2026
Last Update
May 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Toronto Western Hospital
Toronto, Ontario, Canada, M5T2S8